Research Article
AT7867 Inhibits the Growth of Colorectal Cancer Stem-Like Cells and Stemness by Regulating the Stem Cell Maintenance Factor Ascl2 and Akt Signaling
Figure 8
Anticancer efficacy of AT7867 on CSCs derived from CRCs xenografts. (a) Tumors derived from HCT116 CSC-bearing nude mice after 14 days of AT7867 treatment. (b) The growth curves of tumor volume of CSC-bearing mice. (c) Scatter diagrams of tumor weight of H446 CSC-bearing mice. (d, e) Ki67 and TUNEL staining on tumor sections from CSC-bearing mice treated with control, 15 mg/kg, or 25 mg/kg AT7867. (f, g) Immunofluorescent staining of Ascl2 or Survivin on tumor sections from CSC-bearing mice. , , and .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |